Gene Synthesis

De novo gene synthesis technologies enable the development and optimization of antigen-presenting viral genes for safe and rapid vaccine development. GENEWIZ’s synthetic DNA solutions can also be utilized to rapidly produce standard/controls for the development of coronavirus diagnostic assays.

Oligo

Scientists can now order primers and probes approved by the Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), and Chinese government for rapid identification of the virus.

Please see the available list of primers and probes here. HPLC purified COVID-19 primers and probes are available for direct order through our e-commerce platform. Note, all primers and probes are Research Use Only (RUO).

Next Generation Sequencing

NGS continues to play an indispensable role in characterizing and understanding the rapid spread of the coronavirus across the globe. Technologies such as whole genome sequencing and targeted amplicon sequencing can help discover, identify, and monitor pathogenic sequences. 

GENEWIZ’s NGS service portfolio is uniquely positioned to help you identify and uncover known and emerging viruses. 

PCR + Sanger Services

GENEWIZ’s PCR + Sanger workflows provide streamlined services from extraction to data analysis. These assays can facilitate the identification of viral strains, as well as characterize cell lines for vaccine development, at the RUO, GLP, and CLIA service levels.

Sanger Sequencing

GENEWIZ’s award-winning Sanger sequencing services are crucial for advancing COVID-19 research and vaccine development from viral strain identification to antigen sequence verification at the RUO, GLP, and CLIA service levels.